| 1 |
Hori M, Suzuki Y, Sofue K, et al. Artificial intelligence in imaging diagnosis of liver tumors: current status and future prospects[J]. Abdom Radiol, 2026, 51(1): 446-457.
|
| 2 |
刘璐豪, 周舟. 影像组学在肝细胞癌精准诊疗及预后评估中的研究进展[J]. 磁共振成像, 2025, 16(1): 216-221, 227.
|
| 3 |
李永海, 荚卫东. 人工智能影像组学在肝细胞癌精准诊治中的研究进展[J]. 中华肝脏病杂志, 2020, 28(11): 905-909.
|
| 4 |
Huang Z, Zhu RH, Li S, et al. CEUS in prediction of early recurrence of hepatocellular carcinoma after curative resection and to stratify the risk of early recurrence: a retrospective observational study[J]. Abdom Radiol, 2024, 49(6): 1870-1880.
|
| 5 |
Shan QY, Hu HT, Feng ST, et al. CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation[J]. Cancer Imaging, 2019, 19(1): 11.
|
| 6 |
罗曦, 廖福顺, 黄肖雅, 等. 影像组学与人工智能术前预测肝细胞癌微血管侵犯的研究进展[J]. 磁共振成像, 2025, 16(3): 205-210.
|
| 7 |
Sun BY, Gu PY, Guan RY, et al. Deep-learning-based analysis of preoperative MRI predicts microvascular invasion and outcome in hepatocellular carcinoma[J]. World J Surg Oncol, 2022, 20(1): 189.
|
| 8 |
吴阳, 张万广. 人工智能在肝癌精准诊疗中的研究进展[J]. 中国普通外科杂志, 2025, 34(1): 33-39.
|
| 9 |
袁惊雷, 谢晓桐, 张佩娜, 等. 基于CT和MRI影像组学的机器学习模型预测肝癌早期复发的研究进展[J]. 磁共振成像, 2022, 13(12): 154-158.
|
| 10 |
Song S, Zhang G, Yao Z, et al. Deep learning based on intratumoral heterogeneity predicts histopathologic grade of hepatocellular carcinoma[J]. BMC Cancer, 2025, 25(1): 497.
|
| 11 |
Park J, Bae JS, Kim JM, et al. Development of a deep-learning model for classification of LI-RADS major features by using subtraction images of MRI: a preliminary study[J]. Abdom Radiol, 2023, 48(8): 2547-2556.
|
| 12 |
Duc VT, Chien PC, Huyen LDM, et al. Deep learning model with convolutional neural network for detecting and segmenting hepatocellular carcinoma in CT: a preliminary study[J]. Cureus, 2022, 14(1): e21347.
|
| 13 |
Rocha BA, Ferreira LC, Vianna LGR, et al. Contrast phase recognition in liver computer tomography using deep learning[J]. Sci Rep, 2022, 12(1): 20315.
|
| 14 |
Ouhmich F, Agnus V, Noblet V, et al. Liver tissue segmentation in multiphase CT scans using cascaded convolutional neural networks[J]. Int J Comput Assisted Radiol Surg, 2019, 14(8): 1275-1284.
|
| 15 |
Ding W, Meng Y, Ma J, et al. Contrast-enhanced ultrasound-based AI model for multi-classification of focal liver lesions[J]. J Hepatol, 2025, 83(2): 426-439.
|
| 16 |
Xia H, Huang Q, Huang Z, et al. Multimodal deep learning model for predicting prognosis following radiotherapy-based combination therapy in unresectable hepatocellular carcinoma[J]. Cancer Lett, 2026, 636: 218122.
|
| 17 |
Peng J, Kang S, Ning Z, et al. Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging[J]. Eur Radio, 2020, 30(1): 413-424.
|
| 18 |
Cao L, Wang Q, Hong J, et al. MVI-TR: a transformer-based deep learning model with contrast-enhanced CT for preoperative prediction of microvascular invasion in hepatocellular carcinoma[J]. Cancers, 2023, 15(5): 1538.
|
| 19 |
Zhu Y, Liu T, Chen J, et al. Prediction of therapeutic response to transarterial chemoembolization plus systemic therapy regimen in hepatocellular carcinoma using pretreatment contrast-enhanced MRI based habitat analysis and crossformer model[J]. Abdom Radiol, 2024, 50(6): 2464-2475.
|
| 20 |
Zhang K, Ru J, Wang W, et al. Vision transformer-based model can optimize curative-intent treatment for patients with recurrent hepatocellular carcinoma[J]. Nat Commun, 2025, 16(1): 4081.
|
| 21 |
Zhang Y, Sheng R, Qian X, et al. Deep learning empowered gadolinium-free contrast-enhanced abbreviated MRI for diagnosing hepatocellular carcinoma[J]. JHEP Rep, 2025, 7(5): 101392.
|
| 22 |
Lin C, Cao T, Tang M, et al. Predicting hepatocellular carcinoma response to TACE: a machine learning study based on 2.5D CT imaging and deep features analysis[J]. Eur J Radiol, 2025, 187: 112060.
|
| 23 |
Qu H, Zhang S, Li X, et al. A deep learning model based on self-supervised learning for identifying subtypes of proliferative hepatocellular carcinoma from dynamic contrast-enhanced MRI[J]. Insights Imaging, 2025, 16(1): 89-101.
|
| 24 |
Li M, Zhang Z, Chen Z, et al. Interactive explainable deep learning model for hepatocellular carcinoma diagnosis at gadoxetic acid–enhanced MRI: a retrospective, multicenter, diagnostic study[J]. Radiol Imaging Cancer, 2025, 7(3): e240332.
|
| 25 |
Chen Y, Pasquier D, Verstappen D, et al. An interpretable ensemble model combining handcrafted radiomics and deep learning for predicting the overall survival of hepatocellular carcinoma patients after stereotactic body radiation therapy[J]. J Cancer Res Clin Oncol, 2025, 151(2): 84-94.
|
| 26 |
Wang T, Deng Y, Wang S, et al. Kinetic 18F-FDG PET/CT imaging of hepatocellular carcinoma: a dual input four-compartment model[J]. EJNMMI Phys, 2024, 11(1): 20-33.
|
| 27 |
Qin Y, Zhang LG, Zhou X, et al. Explainable fusion model for predicting postoperative early recurrence in hepatocellular carcinoma using gadoxetic acid-enhanced MRI habitat imaging[J]. Acad Radiol, 2025, 32(9): 5162-5172.
|
| 28 |
Wang F, Chen Q, Chen Y, et al. A novel multimodal deep learning model for preoperative prediction of microvascular invasion and outcome in hepatocellular carcinoma[J]. Eur J Surg Oncol, 2023, 49(1): 156-164.
|
| 29 |
Lei Y, Feng B, Wan M, et al. Predicting microvascular invasion in hepatocellular carcinoma with a CT- and MRI-based multimodal deep learning model[J]. Abdom Radiol, 2024, 49(5): 1397-1410.
|
| 30 |
Wang T, Chen H, Chen Z, et al. Prediction model of early recurrence of multimodal hepatocellular carcinoma with tensor fusion[J]. Phys Med Biol, 2024, 69(12): 125003.
|
| 31 |
Şahin E, Tatar OC, Ulutaş ME, et al. Diagnostic performance of deep learning applications in hepatocellular carcinoma detection using computed tomography imaging[J]. Turk J Gastroenterol, 2025, 36(2): 124-130.
|
| 32 |
姜玉新, 王红燕, 李建初, 等. 人工智能与超声质控的深度融合: 赋能精准医疗与同质化发展[J/OL]. 中华医学超声杂志(电子版), 2025, 22(5): 383-387.
|
| 33 |
Li W, Lv XZ, Zheng X, et al. Machine learning-based ultrasomics improves the diagnostic performance in differentiating focal nodular hyperplasia and atypical hepatocellular carcinoma[J]. Front Oncol, 2021, 11: 544979.
|
| 34 |
Lee IC, Tsai YP, Lin YC, et al. A hierarchical fusion strategy of deep learning networks for detection and segmentation of hepatocellular carcinoma from computed tomography images[J]. Cancer Imaging, 2024, 24(1): 43-53.
|
| 35 |
Ma Y, Gong Y, Qiu Q, et al. Research on multi-model imaging machine learning for distinguishing early hepatocellular carcinoma[J]. BMC Cancer, 2024, 24(1): 363-375.
|
| 36 |
Liu N, Wu Y, Tao Y, et al. Differentiation of hepatocellular carcinoma from intrahepatic cholangiocarcinoma through MRI radiomics[J]. Cancers, 2023, 15(22): 5373.
|
| 37 |
Xiao M, Deng Y, Zheng W, et al. Machine learning model based on dynamic contrast-enhanced ultrasound assisting LI-RADS diagnosis of HCC: a multicenter diagnostic study[J]. Heliyon, 2024, 10(20): e38850.
|
| 38 |
Zhang H, Guo D, Liu H, et al. MRI-based radiomics models to discriminate hepatocellular carcinoma and non-hepatocellular carcinoma in LR-M according to LI-RADS version 2018[J]. Diagnostics, 2022, 12(5): 1043.
|
| 39 |
Gao L, Xiong M, Chen X, et al. Multi-region radiomic analysis based on multi-sequence MRI can preoperatively predict microvascular invasion in hepatocellular carcinoma[J]. Front Oncol, 2022, 12: 818681.
|
| 40 |
Qin Q, Pang J, Li J, et al. Transformer model based on sonazoid contrast-enhanced ultrasound for microvascular invasion prediction in hepatocellular carcinoma[J]. Med Phys, 2025, 52(7): e17895.
|
| 41 |
Cai C, Wang L, Tao L, et al. Imaging-based prediction of ki-67 expression in hepatocellular carcinoma: a retrospective study[J]. Cancer Med, 2025, 14(4): e70562.
|
| 42 |
Hu X, Zhou J, Li Y, et al. Added value of viscoelasticity for MRI-based prediction of ki-67 expression of hepatocellular carcinoma using a deep learning combined radiomics (DLCR) model[J]. Cancers, 2022, 14(11): 2575.
|
| 43 |
Zuo XY, Liu HF. Biparametric magnetic resonance imaging-based radiomic and deep learning models for predicting ki-67 risk stratification in hepatocellular carcinoma[J]. World J Hepatol, 2025, 17(8): 109530.
|
| 44 |
Yu H, Kong D, Mo X, et al. MRI-based 2.5D deep learning and radiomics effectively predicted microvascular invasion and ki-67 expression in hepatocellular carcinoma[J]. PLoS One, 2025, 20(11): e0336579.
|
| 45 |
Ren Y, Bo L, Shen B, et al. Development and validation of a clinical-radiomics model to predict recurrence for patients with hepatocellular carcinoma after curative resection[J]. Med Phys, 2023, 50(2): 778-790.
|
| 46 |
Wu C, Yu S, Zhang Y, et al. CT-based radiomics nomogram improves risk stratification and prediction of early recurrence in hepatocellular carcinoma after partial hepatectomy[J]. Front Oncol, 2022, 12: 896002.
|
| 47 |
Hui RWH, Chiu KWH, Lee IC, et al. Multimodal multiphasic preoperative image-based deep-learning predicts HCC outcomes after curative surgery[J]. Hepatology, 2025, 82(2): 344-356.
|
| 48 |
Peng J, Wang J, Zhu H, et al. Three-dimensional multimodal imaging for predicting early recurrence of hepatocellular carcinoma after surgical resection[J]. J Adv Res, 2026, 81: 865-875.
|
| 49 |
Choi GH, Yun J, Choi J, et al. Development of machine learning-based clinical decision support system for hepatocellular carcinoma[J]. Sci Rep, 2020, 10(1): 14855.
|
| 50 |
Zhao Q, He X, Wang K, et al. Deep learning model based on contrast-enhanced ultrasound for predicting early recurrence after thermal ablation of colorectal cancer liver metastasis[J]. Eur Radio, 2022, 33(3): 1895-1905.
|
| 51 |
Wang Y, Weng W, Liang R, et al. Predicting T cell-inflamed gene expression profile in hepatocellular carcinoma based on dynamic contrast-enhanced ultrasound radiomics[J]. J Hepatocell Carcinoma, 2023, 10: 2291-2303.
|
| 52 |
Jin ZC, Wei J, Xiao YD, et al. Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204)[J]. Hepatology, 2025 Nov 10. Online ahead of print.
|
| 53 |
Lin Z, Wang W, Yan Y, et al. A deep learning-based clinical-radiomics model predicting the treatment response of immune checkpoint inhibitors (ICIs)-based conversion therapy in potentially convertible hepatocelluar carcinoma patients: a tumor marker prognostic study[J]. Int J Surg, 2025, 111(5): 3342-3355.
|
| 54 |
Chen C, Han Q, Ren H, et al. Multiparametric MRI‐based model for prediction of local progression of hepatocellular carcinoma after thermal ablation[J]. Cancer Med, 2023, 12(17): 17529-17540.
|
| 55 |
Hashimoto K, Haraguchi T, Nawata S, et al. Creation of a prediction model of local tumor recurrence after a successful conventional transcatheter arterial chemoembolization using cone-beam computed tomography based–radiomics[J]. CardioVasc Interventional Radiol, 2024, 47(11): 1495-1505.
|
| 56 |
Xu J, Li J, Wang T, et al. Predicting treatment response and prognosis of immune checkpoint inhibitors-based combination therapy in advanced hepatocellular carcinoma using a longitudinal CT-based radiomics model: a multicenter study[J]. BMC Cancer, 2025, 25(1): 602-618.
|
| 57 |
Carbonell G, Kennedy P, Bane O, et al. Precision of MRI radiomics features in the liver and hepatocellular carcinoma[J]. Eur Radio, 2022, 32(3): 2030-2040.
|
| 58 |
Chierici A, Lareyre F, Iannelli A, et al. Applications of artificial intelligence in liver cancer: a scoping review[J]. Artif Intell Med, 2025, 169: 103244.
|
| 59 |
Gao W, Wang W, Song D, et al. A predictive model integrating deep and radiomics features based on gadobenate dimeglumine-enhanced MRI for postoperative early recurrence of hepatocellular carcinoma[J]. Radiol Med, 2022, 127(3): 259-271.
|
| 60 |
Xu Y, Zhou C, He X, et al. Deep learning–assisted LI-RADS grading and distinguishing hepatocellular carcinoma (HCC) from non-HCC based on multiphase CT: a two-center study[J]. Eur Radiol, 2023, 33(12): 8879-8888.
|
| 61 |
Hendriks P, Boel F, Oosterveer TT, et al. Ablation margin quantification after thermal ablation of malignant liver tumors: how to optimize the procedure? A systematic review of the available evidence[J]. Eur J Radiol Open, 2023, 11: 100501.
|
| 62 |
Zeng Q, Klein C, Caruso S, et al. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study[J]. Lancet Oncol, 2023, 24(12): 1411-1422.
|
| 63 |
杨月, 梁秀婷, 王盈盈, 等. 人工智能辅助消化道内镜诊断系统的应用与展望[J]. 中国临床医生杂志, 2025, 53(4): 405-407.
|